The Biosynthetic Gene Cluster for a Monocyclic β-Lactam Antibiotic, Nocardicin A  by Gunsior, Michele et al.
Chemistry & Biology, Vol. 11, 927–938, July, 2004, 2004 Elsevier Ltd. All rights reserved. DOI 10.1016/j .chembiol .2004.04.012
The Biosynthetic Gene Cluster for a Monocyclic
-Lactam Antibiotic, Nocardicin A
linked homoseryl terminus (Figure 1). The presence of the
oxime, and its syn relation to the acylamino group, as well
as the 3-amino-3-carboxypropyl side chain are critical
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Department of Chemistry for antimicrobial activity [7]. Interestingly, in contrast to
The Johns Hopkins University other antibiotics such as carbenicillin, the activity of
3400 North Charles Street nocardicin A is higher in vivo than in vitro [8].
Baltimore, Maryland 21218 Precursor incorporation studies of 1 have shown its
biosynthetic origin in L-serine and two units of the non-
proteinogenic amino acid L-pHPG [9, 10], while L-methi-
Summary onine provides the homoseryl side chain [11, 12]. During
fermentation L-pHPG is much more efficiently utilized
The monocyclic -lactam antibiotic nocardicin A is re- by N. uniformis than the D-enantiomer [13]. In addition
lated structurally and biologically to the bicyclic -lac- it was shown that the oxime is formed by amine oxida-
tams comprised of penicillins/cephalosporins, clavams, tion [9]. Further biosynthetic studies demonstrated that
and carbapenems.Biosynthetic gene clusters are known the amino acid precursors of nocardicin A are assem-
for each of the latter, but not for monocyclic -lactams. bled at the correct oxidation state [11], and the stereo-
A previously cloned gene encoding an enzyme specific chemical course of -lactam ring formation in vivo oc-
to the biosynthetic pathway was used to isolate the curs with inversion of configuration at the seryl -carbon
nocardicin A cluster from Nocardia uniformis. Sequence [13, 14].
analysis revealed the presence of 14 open reading The most direct mechanistic rationale for the forma-
frames involved in antibiotic production, resistance, and tion of the monocyclic -lactam consistent with the
export. Among these are a two-protein nonribosomal above results is intramolecular nucleophilic displace-
peptide synthetase system, p-hydroxyphenylglycine bio- ment of a presumably activated seryl hydroxyl in an
synthetic genes, an S-adenosylmethionine-dependent amide precursor. An attractive mechanism of serine acti-
3-amino-3-carboxypropyl transferase (Nat), and a cyto- vation, although not the only possibility, is in vivo phos-
chrome P450. Gene disruption mutants of Nat, as well phorylation. Phosphorylation can be mimicked in vitro
as an activation domain of the NRPS system, led to by reaction of a protected serine-containing dipeptide
loss of nocardicin A formation. Several enzymes in- under Mitsunobu conditions where the -lactam prod-
volved in antibiotic biosynthesis were heterologously uct is formed rapidly at room temperature, thus support-
overproduced, and biochemical characterization con- ing the proposed SNi mechanism in a chemical model
firmed their proposed activities. system [15].
The intermediacy of a tripeptide or a related derivative
Introduction was suggested by the efficient and intact incorporation
of nocardicin G (D,L,D) into nocardicin A [16]. However,
In the mid-1970s, researchers at Fujisawa Pharmaceuti- additional feeding studies with a variety of activated and
cals isolated a new antibiotic from the fermentation unactivated di- and tripeptides were unsuccessful [17].
broth of an actinomycete [1], Nocardia uniformis subsp. This failure notwithstanding, it is hypothesized that in
tsuyamanensis, that showed moderate activity against
the initial step two units of L-pHPG and one unit of serine
a broad spectrum of Gram-negative bacteria. Structure
are assembled by a nonribosomal peptide synthetase to
determination of nocardicins A, 1, and B, 2, [2] revealed
yield a D,L,D-tripeptide, or possibly nocardicin G, the
a monocyclic -lactam moiety, as well as uncommon
simplest of the seven known nocardicins.p-hydroxyphenylglycine (pHPG) and oxime units. Unlike
The in vitro characterization of two tailoring enzymesthe bicyclic -lactams, nocardicin A exhibits some
active later in the pathway provided details of nocardicin
-lactamase resistance as a result of its relatively more
A biosynthesis. The protein Nat, responsible for additionstable monocyclic -lactam ring and low affinity by these
of the homoseryl sidechain, catalyzes the biosyntheti-enzymes [3]. Nocardicin A has also been isolated from
cally rare transfer of a 3-amino-3-carboxypropyl groupthe actinomycetes Actinosynnema mirum [4], Nocardi-
from S-adenosyl-L-methionine (AdoMet) to the sub-opsis atra [5], and Microtetraspora caesia [6]. The natu-
strates nocardicin E, F, and G, but significantly prefer-rally occurring nocardicins A-G differ in amine oxidation
ring the latter [18]. NocL (vide infra), a cytochrome P450,state at C-2 and the presence or absence of an ether-
was demonstrated to carry out the formation of the ox-
ime of nocardicin A in the presence of spinach ferro-*Correspondence: ctownsend@jhu.edu
doxin, spinach ferrodoxin-NADP reductase, NADPH,1Present address: National Cancer Institute, Building 37, 9000 Rock-
ville Pike, Bethesda, Maryland 20892. and nocardicin C, 3, [19]. While nocardicin C was a
2Present address: Department of Biochemistry, Box 3711, Duke Uni- substrate for recombinant NocL, reaction of nocardicin
versity Medical Center, Durham, North Carolina 17710. G to nocardicin E or F could not be detected under the
3Present address: The Institute for Genomic Research, 9712 Medical
assay conditions used. The complementary outcomesCenter Drive, Rockville, Maryland 20850.
of these two studies allow the preferred order of the4Present address: Celera Genomics, 180 Kimball Way, South San
Francisco, California 94080. biosynthetic steps to be assigned as shown in Figure 2
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Figure 1. The Nocardicin Family of Antibiotics
[19]. The point at which C-9 epimerization takes place ics” and determined to possess the entire nat gene [18].
Primer walking also revealed the presence of a partialis unknown.
We report in this paper the cloning and sequence gene showing unmistakable homology to nonribosomal
peptide synthetases directly upstream of and overlap-analysis of the nocardicin A biosynthetic gene cluster
from N. uniformis as well as the initial characterization of ping the start codon of nat. An N. uniformis genomic
DNA library was constructed in the E. coli-Streptomycesseveral enzymes involved in its biosynthesis. Sequence
analysis revealed the presence of a pair of nonribosomal shuttle vector pOJ446 [20] and screened using nat and
later nocF, which lies 17 kb upstream. Sixteen positivepeptide synthetases and pHPG biosynthetic genes up-
stream of nat. Biochemical experiments supporting the cosmids were identified from which a total of 54,100
sequenced bases were obtained. Included were approx-proposed functions of these encoded biosynthetic en-
zymes are also described. imately 33.3 kb encoding 14 genes predicted to be re-
sponsible for the assembly, self-resistance, and regula-
tion of nocardicin A (Figure 3). No genes with apparentResults
roles in the biosynthesis of nocardicin A were identified
upstream of nocN (17 kb) or downstream of nocE (5 kb).Identification of the Nocardicin A Cluster
A 6 kb PstI fragment of N. uniformis genomic DNA was A similar approach was used to isolate the nocardicin
A biosynthetic cluster in A. mirum. The data indicatedobtained as described earlier through “reverse genet-
Figure 2. Preferred Biosynthetic Route to Nocardicin A
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Figure 3. Schematic Diagram of the Nocardicin A Cluster
Genes colored in green denote pHPG biosynthesis; yellow, regulation and resistance; orange, tailoring enzymes; blue, nonribosomal peptide
synthetases; and light blue, genes of unknown function. The domain architecture of NocA and NocB is shown enlarged beneath the cluster
map. The black and gray arrows indicate the location of the repeat sequences in NocA. The green and red arrows indicate N termini of the
200 kDa and 150 kDa proteins isolated from wild-type N. uniformis, respectively.
that the organization of the nocardicin A biosynthetic glycine were found within the nocardicin A biosynthetic
cluster. Genes nocF, nocG, and nocN encode a putativecluster in A. mirum was identical to that of N. uniformis,
and that sequence identity was nearly 100% (data not p-hydroxymandelate synthase, p-hydroxyphenylglycine
transaminase, and p-hydroxymandelate oxidase, re-shown). Importantly, the sequence upstream of nocN
and downstream of nocE was shown to be different in spectively. This set of three genes was homologous to
that found in the chloroeremomycin biosynthetic path-A. mirum, suggesting that both nocN and nocE mark
the pathway boundaries. The genetic map of the nocar- way in Amycolatopsis orientalis [22], the calcium-depen-
dent antibiotic (CDA) cluster in Streptomyces coelicolordicin A biosynthetic cluster is shown in Figure 3.
The nocardicin A cluster sequence possessed an A3(2) [23], and the complestatin biosynthetic cluster in
Streptomyces lavendulae [24]. The nocardicin biosyn-overall GC content of 76.0%. In order to ascertain the
putative function of each of the determined open reading thetic cluster does not possess a prephenate dehydro-
genase gene proposed to be involved in pHPG biosyn-frames (ORF), the deduced amino acid sequences were
compared to those in the NCBI protein database using thesis, which is found in all other known clusters
BLAST [21]. The proposed function for each ORF is containing these genes.
compiled in Table 1. The activities of NocF and NocN were characterized
by expression in heterologous systems. Using chiral
HPLC, NocF was determined to stereospecifically con-pHPG Biosynthetic Genes
The genes responsible for the catabolism of L-tyrosine vert p-hydroxyphenylpyruvate to (S )-p-hydroxymande-
late, and NocN was shown to oxidize (S )-pHMA toto the nonproteinogenic amino acid p-hydroxyphenyl-
Table 1. Homology and Deduced Function of ORFs in the Nocardicin A Biosynthetic Pathway
Product
Gene Size (aa) Protein Sequence Homologa Proposed Function
nocE 1414 no significant homology unknown
nocD 185 probable acetyltransferase (AE001997) resistance
nat 301 methyl transferase (AE005808) 3-amino-3-carboxypropyl transferase [18]
nocB 1925 nonribosomal peptide synthetase (syringomycin, module 4 C A T
T14593) module 5 C A T TE
nocA 3692 nonribosomal peptide synthetase (pyoverdin, F83345) module 1 A T
module 2 C A T
module 3 C A T E
nocF 345 p-hydroxymandelate synthase, Hmas (CAA11761) pHPG biosynthesis, p-hydroxymandelate
synthase
nocG 431 p-hydroxyphenylglycine transaminase, pHPG biosynthesis, p-hydroxyphenylglycine
HpgT (CAA11790) transaminase
nocH 408 membrane transport protein (X86780) transport
nocI 74 conserved hypothetical protein of unknown function unknown
(AE004668)
nocJ 327 putative 1-aminocyclopropane-1-carboxylate unknown
deaminase (P756316)
nocK 344 putative hydrolase/esterase (AL583919) unknown
nocL 398 cytochrome P450 (S51594) oxime-forming enzyme [19]
nocR 582 transcriptional activator protein (AF124138) regulation
nocN 376 p-hydroxymandelate oxidase, Hmo (CAA11762) pHPG biosynthesis, p-hydroxymandelate
oxidase
a GenBank protein accession numbers of selected homologs are given in parentheses.
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p-hydroxybenzoylformate. We were unable to heterolo- NocK has high homology to a putative secreted pro-
tein from S. coelicolor A3(2), and LpqC (34% and 29%gously express soluble NocG, which prevented verifica-
tion of this enzyme as a transaminase as demonstrated identity respectively), an M. tuberculosis hypothetical
protein thought to act as an esterase or a poly(3-hydro-by Hubbard et al. [25] for the corresponding gene from
A. orientalis. xyalkanoate) depolymerase [34]. NocK also shows lower
homology (22% identity) to poly(3-hydroxybutyrate) de-
polymerases, a type of serine esterase that hydrolyzesRegulatory/Resistance Genes
polyhydroxyalkanoates to water soluble products [35].NocD shows approximately 30% identity and up to 60%
The translated product of nocE is a large protein ofsimilarity to the superfamily of acetyltransferases that
1414 residues. No homology or conserved domainsincludes N-, O-, and S-acetyltransferases of all types
were discovered when analyzed by BLAST or any ofand function. Of acetyltransferases with known function,
several motif search engines.NocD shows apparent homology to N-acetylases, in-
cluding those of ribosomal proteins from prokaryotic
organisms such as Thermoanaerobacter tengcongensis Tailoring Enzymes
Studies in this laboratory have previously shown that Natand Bacillus halodurans. Acetyltransfer is the predominant
mechanism of antibiotic resistance employed by patho- (NocC) transfers the 3-amino-3-carboxypropyl moeity of
AdoMet to nocardicin G, forming isonocardicin C (thegenic bacteria against aminoglycosides [26], and has also
been implicated in bleomycin self-resistance [27]. C-9 epimer of 3) in an unusual use of the cofactor [18].
Nat possesses weak homology to bacterial AdoMet-The predicted product of nocH has 30% identity and
44% similarity to a membrane transport protein found in utilizing enzymes.
nocL encodes a cytochrome P450 that possessesthe rapamycin biosynthetic cluster from Streptomyces
hygroscopicus. Other homologs include multidrug efflux both the conserved heme binding region FGHGxHxCLG
[19, 36] centered around the invariant cysteine residue,permease and resistance proteins from a variety of or-
ganisms. It is likely that NocH functions by exporting the and a region homologous to an oxygen binding motif
LLxAGHET [37, 38]. The nocardicin A cluster does notantibiotic outside the cell and might be a self-resistance
mechanism. possess an NAD(P)H-dependent reductase or ferro-
doxin gene, two additional enzymes involved in electronThe deduced product of nocR is a large protein of
582 amino acids with a predicted molecular weight of transport and required in bacterial P450 catalysis. It has
been generally observed that all three genes are rarely61.8 kDa. A conserved domain (CD) search reveals a
small region of fewer than 100 residues at the N terminus found in biosynthetic clusters, and it is assumed that
electron transport proteins are recruited from else-homologous to DNA binding domains of various regula-
tors [28], in addition to a region corresponding to a where in cellular metabolism [39]. NocL was demon-
strated to carry out formation of the oxime moiety ofbacterial transcriptional activator domain (BAD). NocR
has homology to transcription regulatory proteins, most nocardicin A in the presence of spinach ferrodoxin, spin-
ach ferrodoxin-NADP reductase, NADPH, and nocar-notably CdaR, a transcriptional activator found in the
biosynthetic cluster of CDA from S. coelicolor (35% dicin C, 3, [19].
Another enzyme not found in the nocardicin A biosyn-identity, 46% similarity), and AsfR, a global regulatory
protein for secondary metabolite biosynthesis from the thetic cluster is the phosphopantetheinyl transferase
(PPTase), required in the conversion of apo-NocA/B tosame organism [29]. Based on this analysis, NocR ap-
pears to be related to the growing family of pathway- holo-NocA/B. Holo-NRPS enzymes possesses 4-phos-
phopantetheine arms, covalently bound to a conservedspecific activators known as SARPs (Streptomyces anti-
biotic regulatory proteins [30]). serine residue in the thiolation domain responsible for
shuttling enzyme bound intermediates between mod-
ules. Genes encoding PPTase enzymes are highly ho-Genes of Unknown Function
mologous and often found adjacent to biosynthetic clus-Gene nocI, encodes a 73 amino acid protein that shows
ters containing peptide synthetases. However, when anhigh homology to a Pseudomonas aeruginosa hypothet-
organism contains two or more NRPS systems, oneical protein (60% identity, 76% similarity). All of the se-
PPTase seems sufficient to modify all systems [40]. Thisquences producing significant homology are small pro-
seems to be the case for nocardicin A. Accordingly,teins ranging in size from 56–80 amino acids. The
nearly identical genes encoding Sfp-subfamily PPTasesfunction of this small class of proteins is unknown, but
were found elsewhere in the genomes of N. uniformis,they are typically present in NRPS and mixed NRPS/
and A. mirum (J.R. and C.A.T., unpublished data). ThisPKS systems.
family of enzymes has the ability to modify both type IThe deduced amino acid sequence of NocJ has low
and type II acyl carrier proteins and peptidyl carrierhomology (23% identity, 33% similarity) to 1-aminocy-
proteins.clopropane-1-carboxylate (ACC) deaminases, a PLP-
dependent protein involved in the metabolism of ACC
to -ketobutyrate and ammonia [31, 32]. An alignment NRPS Biosynthetic Genes
Sequence analysis showed that NocA and NocB belongof NocJ with putative and known ACC deaminases indi-
cates that NocJ possesses a critical lysine that binds to the growing family of nonribosomal peptide synthe-
tases. The coding sequence of the peptide synthetasesPLP within the conserved sequence VFGGCKTRALEF
[33], which has been confirmed by experiment (W.L. spans 17 kb corresponding to 3692 and 1925 amino
acids, respectively. The protein sequence was exam-Kelly and C.A.T., unpublished data).
Nocardicin Biosynthetic Cluster
931
Table 2. Prediction of Amino Acid Substrate for NocA and NocB Adenylation Domains
A Domain Homologous Sequence Substrate Prediction
CepB-A1 D-I-F-H-L-G-L-L
Cda1-A6 D-V-Y-H-L-G-L-L
BpsB-A4 D-I-F-H-L-G-L-L
L-PHPGNocA-A1 D-I-W-H-V-G-A-I
NocA-A3 D-I-W-H-V-G-T-I
NocB-A5 D-I-W-H-L-G-A-I
SyrE-A3 D-V-W-H-L-S-L-I
NosA-A2 D-V-W-H-I-S-L-I
L-Ser
PvdD-A1 D-V-W-H-I-S-L-I
NocB-A4 D-V-W-H-L-S-L-I
ApdB-A2 D-V-E-N-A-G-V-V
FxbC-A1 D-M-E-N-L-G-L-I L-5NhOrn
NocA-A2 D-V-E-N-V-G-A-I
Abbreviations are as follows: CepB, chloroeremomycin synthetase; Cda1, calcium-dependent antibiotic peptide synthetase 1; BspB, balhimycin
synthetase; SyrE, syringomycin synthetase; NosA, nostopeptilide synthetase, PvdD, pyoverdine synthetase; ApdB: anabaenopeptilide synthe-
tase B; FxbC: exochelin synthetase; L-5NhOrn: L-N5-hydroxyornithine.
ined for the presence of standard NRPS motifs [41]. The A3 of exochelin biosynthesis [47], and CchH-A3 of coeli-
chelin synthetase [48]. Known ornithine-activating do-result of this analysis indicated a departure from the
canonical domain organization, in which the enzyme(s) mains have a universally conserved E278/S322 dyad
believed to form hydrogen bonds with the terminalresponsible for producing a D,L,D-tripeptide would be
expected to be composed of three modules, the first amine/ammonium. In 5NhOrn A-domain substrate bind-
ing pockets, E278 is replaced by asparagine, and S322and third of which would also contain epimerization do-
mains. In contrast, NocA and NocB together possess by leucine or glycine. NocA-A2 and ApdB-A2 do not
possess the E278/S322 dyad conserved in the bindingfive modules and only one epimerization domain, as
shown in Figure 3. Furthermore, NocB begins with an pocket of ornithine-activating A domains. The differ-
ences between NocA2-A2 and ApdB-A2 are conserva-adenylation domain rather than a conventionally ob-
served condensation domain, which is located at the C tive changes, and given the close homology to 5NhOrn-
activating domains, it is possible that both activate thisterminus of NocA. Thus, the two enzymes involved in
nocardicin A biosynthesis can each be classified as a substrate or possibly ornithine.
Both nocB-A4 and nat were disrupted with a thiostrep-Type C NRPS [42].
It is now possible to predict A-domain substrate spec- ton gene cassette resulting in the complete loss of no-
cardicin A production. Disappointingly, no detectableificity by comparison of eight critical residues lining the
amino acid binding pocket to other known A-domains accumulation of nocardicin E, 5, or nocardicin G, 7,
was observed in the nat disruption mutants when grown[43, 44]. Table 2 shows the eight residue motifs for each
of the NocA and NocB A-domains with their predicted under production conditions (Figure 4). Complementa-
tion of the disrupted nat gene, however, with a full-substrate.
Alignments of the substrate recognition residues of length transcript expressed under the ermE* constitutive
promoter on shuttle vector pULVK2A [49] restored pro-putative serine-activating A-domains show a universally
conserved H278/S301 dyad believed to play a functional duction of nocardicin A to at least a low level, confirming
the critical role of Nat in its biosynthesis. The HPLCrole in hydrogen bonding of the substrate hydroxyl [43].
NocB-A4 shows high homology to domains activating peak arising from complementation was shown to be
nocardicin A by ESI-MS and MS/MS comparisons toserine and possesses both H278/S301. pHPG-activating
domains are remarkably similar to serine domains, but authentic material. We can conclude, therefore, that the
gene cluster isolated and characterized is, indeed, re-contain a S301→G301 substitution [43]. The specificity-
conferring residues of NocA-A1, NocA-A3, and NocB- sponsible for nocardicin A biosynthesis.
A5 are similar to other pHPG domains, and all three
possess a glycine residue at position 301. Recently an Overexpression of NocA/B Adenylation Domains
Many attempts were made to overexpress the adenyla-A-domain from the balhimycin antibiotic biosynthetic
cluster (BpsB-A4) in Amycolatopsis mediterranei [45] was tion domains of NocA/B in E. coli in an effort to biochemi-
cally validate the substrate predictions and correlate tooverexpressed and shown to activate L-pHPG. According
to our analysis, the BpsB-A4 substrate specificity motif earlier whole-cell incorporation experiments. A-domains
of NocA/B A1-A5 were cloned into a variety of expres-closely matches those of all three predicted nocardi-
cin A pHPG A-domains, and other pHPG A-domains (Ta- sion vector systems. Despite repeated efforts varying
the expression system and host, the affinity tags, theble 2).
The specificity-conferring residues of NocA-A2 show size of the constructs, the temperature for expression,
and the addition of the E. coli chaperones GroES/EL,[50]highest homology to the substrate binding pocket of
anabaenopeptilide synthetase B-A2 (ApdB-A2) [46], no soluble, active proteins were obtained. Insolubility
and low expression of adenylation domains is not limitedL-N5-hydroxyornithine (5NhOrn) activating FxbC-A1 and
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Figure 4. Disruption and Complementation
of the nat Gene and HPLC Analysis
Chromatograms of supernatants from (A)
wild-type N. uniformis, (B) disruption mutant
nat::tsr, and (C) complementation mutant
pAJL3248 nat::tsr are shown. Nocardicin G
(*) and nocardicin A (•) peaks were confirmed
by coinjection of authentic material. Inset:
Disruption of nat in the plasmid pAJL3118
with the thiostrepton resistance cassette.
to NocA/B; these problems have been encountered in G was detected when the 200 kDa protein was incubated
with the required precursors, in keeping with the colin-NRPSs involved in enterobactin, bleomycin, and myco-
bactin biosynthesis, among others [51, 52]. earity rule.
The N-terminal sequences of the 200 kDa and 150
kDa proteins were obtained following transfer to a PVDFNRPS Characterization
Two proteins, 200 kDa and 150 kDa in lesser, variable membrane. Sequencing of the former yielded approxi-
mately 20 N-terminal amino acids that did not showamounts as estimated by SDS-PAGE, were purified to
near homogeneity from N. uniformis based on their homology to any known nonribosomal peptide synthe-
tase in the database, but corresponded exactly to theability to catalyze ATP/PPi exchange in the presence of
L-pHPG. PPi exchange in the presence of L-pHPG was first 20 residues of NocB. The N-terminal sequence of
the 150 kDa protein yielded 11 amino acids that corre-30 times higher than for D-pHPG, and ten times higher
than L-phenylalanine indicating that a Phe-tRNA synthe- sponded to the beginning of module 5 in NocB, as indi-
cated by the red arrow in Figure 3.tase had not been isolated. Exchange in the presence
of L-serine was less efficient, but nonetheless was re-
producibly 3-4 times higher than that observed for the Discussion
negative control. Importantly, the 150 kDa enzyme failed
to give exchange detectable above background when It was postulated from precursor incorporation experi-
ments and the presence of D-pHPG residues that nocar-assayed with L-serine. Failure to stimulate exchange
was also observed with L-tyrosine, L-tryptophan, L- and dicin A would be biosynthesized by way of NRPS en-
zymes. Sequencing of the nocardicin A biosyntheticD-phosphoserine in both the 200 and 150 kDa enzymes.
The 200 kDa enzyme was inactivated in the presence gene cluster confirmed this hypothesis and also shed
light on other aspects of its formation, including someof sulfhydryl modifying reagents such as p-chloromerc-
uribenzoate, N-ethylmaleimide, or iodoacetamide, sug- of the unusual structural features of the molecule such
as the oxime, the homoseryl side chain, and the twogesting that a reactive sulfhydryl group is central to the
chemistry performed by this enzyme. Additionally, the pHPG units. Disruptions of nocB-A4 and nat resulted in
complete loss of nocardicin A production indicating thatpresence of 4-phosphopantetheine in this enzyme was
shown by release of D-pantothenate through the action the isolated gene cluster was responsible for formation
of the monocyclic -lactam. Nocardicin A productionof alkaline phosphatase and biochemical assay [53].
Further experiments assayed the ability of the 200 kDa was restored by complementation with a full-length
copy of the late-stage biosynthetic gene nat. Compari-protein to promote peptide formation and epimerization.
Incubation with radiolabeled substrates L-[2-3H,1-14C]- son of the virtually identical clusters found in N. uni-
formis and A. mirum suggested that nocN and nocEpHPG and D-[2-3H,1-14C]-pHPG, was monitored by
HPLC and scintillation counting. The absence of a de- delineate the pathway boundaries.
The genes involved in pHPG biosynthesis were foundcrease in (3H/14C) ratio in each of the substrates indicated
that the protein did not catalyze in vitro epimerization. clustered in the nocardicin A biosynthetic pathway, simi-
lar to other systems [22, 23], with the exception of pre-In addition, neither the (D,L,D)-tripeptide, nor nocardicin
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phenate dehydrogenase (PDH), an enzyme normally in- completion of the peptide product by a separate en-
zyme. Such a peptide isomerase has been purified fromvolved in aromatic amino acid biosynthesis. PDH, which
catalyzes the formation of p-hydroxyphenylpyruvate funnel web spider venom and shown to interconvert the
configuration of a single serine residue in a 48-amino-(pHPP) from prephenate and found in other pHPG path-
ways, is absent from the nocardicin A cluster, sug- acid peptide [54]. (2) An epimerase similar to that found
in the biosynthesis of cyclosporin A [55] inverts the ste-gesting that pHPP is obtained from primary metabolism
and not a separate, dedicated enzyme. reochemistry of L-pHPG prior to activation. This possi-
bility is unlikely as biochemical experiments with NocBTwo large enzymes of 200 kDa and 150 kDa with the
ability to catalyze L-pHPG-dependent ATP/PPi ex- indicate that in the presence of L-pHPG ATP/PPi ex-
change occurs 30 times more efficiently than withchange were purified from N. uniformis. Experiments
with the larger of the two confirmed the presence of D-pHPG, and is also inconsistent with our experiments
using [2-3H,1-14C]-pHPG. (3) The C-5 position is benzylica reactive sulfhydryl group in the enzyme, as well as
independent demonstration of a phosphopantetheine and known to be base-labile [56]. The pKa of this hydro-
gen is similar to that of an amide and epimerization atprosthetic group. N-terminal sequence of the 200 kDa
protein mapped to the first 20 amino acids of NocB this center could occur in tandem with deprotonation
of the adjacent amide and -lactamization.(green arrow, Figure 3). The observed molecular weight
corresponded well with the calculated mass of 206 kDa A possibility to account for tripeptide formation in this
five module NRPS system is that M1 and M2 are inactive.for NocB. NocB possesses only two modules, and,
therefore, cannot catalyze tripeptide synthesis alone. Related examples of inactive domains have been docu-
mented in the condensation domain of VibF in vibriobac-N-terminal sequence data of the 150 kDa protein
showed identity to a region of NocB four amino acids tin biosynthesis, [57] and the adenylation domain of
module NRPS-0 in bleomycin formation [52, 58]. Primaryupstream of the condensation domain motif C1 of mod-
ule 5 (shown by the red arrow in Figure 3), indicating sequence alignments of NocA indicate no anomalies in
the core catalytic domains but does reveal two regionsthat the smaller enzyme is a proteolytic fragment of
NocB of 140.5 kDa. The site of proteolysis accounts of additional sequence containing short amino acid re-
peats that are not present in other NRPSs. The first,for experimentally determined substrate specificity of
module 5 and allows the function of module 4 to be approximately 40 residues in length, is located just be-
fore the thiolation domain of M1 (shown by the blackdeduced. The 150 kDa enzyme catalyzed PPi exchange
with L-pHPG, but not the D-isomer or several other arrow in Figure 3) and contains a disproportionate num-
ber of glycine and proline residues. The second regionamino acids including L-serine. These experiments
prove that module 5 contains a pHPG A-domain, and, is larger, spanning 90 residues following the thiolation
domain of M2 (gray arrow, Figure 3), and also containstherefore, module 4 likely activates L-serine in keeping
with predictions [43]. Attempts to determine the sub- a high number of glycine, alanine, valine, and proline
residues. At the DNA level, the third position GC bias instrate specificity of the other adenylation domains of
NocA through expression of autonomous enzymes were this region drops to 60% from nearly 100%. The role of
these repeats is unknown, but it might affect the tertiaryunsuccessful. However, the binding pockets of three
A-domains in NocA and NocB proposed to activate structure of these modules, hence inactivating them. If
this were the case, a dipeptidyl product could be formed,pHPG are highly homologous; therefore, it is likely that
NocA-A1 and NocA-A3, like NocB-A5, recognize and or the substrate amino acids of both modules could
be activated individually, but spatial deformities wouldadenylate pHPG.
The mechanism by which the core peptide structure prevent condensations from taking place by interfering
with transfer(s) to M3. The proposed substrates of theis formed remains unclear. NocA and NocB do not follow
the NRPS colinearity paradigm, and the presence of five remaining modules 3 through 5, when linked by amide
bonds, lead to the core nocardicin tripeptide, pHPG-modules instead of the three expected for tripeptide
formation complicates the interpretation. Furthermore, Ser-pHPG. The role of these short repeats probably dif-
fers from that of the unique and quite faithfully dupli-the earliest known intermediate nocardicin G contains
two D-pHPG units, while NocA and NocB contain only cated hexapeptide motifs at the C terminus of BlmIV.
Recent studies of bleomycin biosynthesis have unequiv-one epimerization domain. In the absence of biochemi-
cal data, the formation of a product of the correct stereo- ocally demonstrated the essential function of these
C-terminal repeats exert in protein-protein interactionschemistry can only be speculated.
Based on the configurations of the amino acids com- with BlmIII to enable bithiazole formation to occur [58].
In a second possible mechanism for the formation ofprising nocardicin G (D,L,D), and experiments that deter-
mined the stereochemistry of the substrate amino acids the core tripeptide, if all five modules were active, the
resulting pentapeptide could be processed down to ato be the L-enantiomers, a peptide synthetase system
comprising three modules, the first and third of which tripeptide. Many bacterial systems possess proteolytic
enzymes whose substrates are small peptides com-contain epimerization domains, was anticipated. Se-
quence analysis indicates modules 3, 4, and 5 might be posed of naturally occurring L-amino acids, while pep-
tides containing D-epimers are more stable [59]. Theresponsible for formation of a tripeptide intermediate as
these adenylation domains activate pHPG, serine, and first two modules likely incorporate L-residues, and con-
sequently the first two residues of the pentapeptidepHPG, respectively. Module 3 (M3) has an epimerization
domain (Figure 3) while M5 does not. Several possibilit- could be enzymatically cleaved to give a tripeptide,
which is then resistant to further cleavage by virtue ofies could account for the absence of an M5 epimeriza-
tion domain: (1) The position is epimerized following a D-pHPG configuration at the N terminus.
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Figure 5. Proposed Formation of Hydroxamate and Tripeptide
Finally, it is predicted that M2 activates and incorpo- fectious diseases. Rapid advances are being made
rates N5-hydroxyornithine or ornithine. A 6-membered currently to both elucidate and engineer natural prod-
ring might be formed in a favored 6-exo trig cyclization uct biosynthetic pathways at the genetic level for the
[60] through intramolecular attack of the N5-hydroxyor- production of new antibiotics. In this paper, we have
nithine or ornithine side chain, on the amide carbonyl, described the isolation and initial characterization of
resulting in a hydroxamic acid/-lactam and a tripeptide the nocardicin A biosynthetic gene cluster from N.
(Figure 5). A similar mechanism has been proposed in uniformis and A. mirum, the first example of a monocy-
the biosynthesis of coelichelin [48] to effect cleavage clic member of the -lactam family. This result marks
of the putative tripeptide from the thiolation domain of the completion of at least one representative gene
CchH. Such a self-editing event could occur in nocar- cluster sequence from each of the four known sub-
dicin G biosynthesis while covalently attached to NocA classes of these antibiotics. The noc cluster contains
so that only D-pHPG, the substrate of M3, is translo- 14 genes for formation, resistance, and export of no-
cated and elongated; or intrapeptide cleavage might cardicin A. Among these are the genes necessary for
occur after the pentapeptide is free in solution. If the synthesis of the nonproteinogenic amino acid pHPG,
two repeat sequences do affect tertiary structure and, a P450 involved in oxime formation, and an AdoMet-
hence, the native processivity, the likelihood of self- dependent transferase that attaches an aminocarbox-
cleavage while linked to NocA is much greater. A postu- ypropyl group to the phenolic oxygen of pHPG. As is
lated mechanism for hydroxamate formation is shown frequently observed in natural product biosynthetic
in Figure 5. Early release of a growing peptide in NRPS pathways, some of the encoded biosynthetic proteins
synthesis has been shown to occur; incorporation of possess primary sequence similarity to known en-
ornithine in an engineered surfactin synthetase I NRPS zymes, but have evolved to perform new roles in the
altered the conformation of the surfactin product and creation of natural products. There are also gene prod-
resulted in premature cyclization, although the products ucts whose function is wholly unknown. A pair of NRPS
obtained in this experiment were not those expected enzymes thought to be responsible for peptide forma-
based on mass spectrometric characterization. The tion does not follow the colinearity paradigm and may
lower m/z ions observed suggested more extensive catalyze unknown transformations, such as epimeri-
modifications had taken place, but the exact structures
zation in the absence of a specific domain or possibly
are not known [61].
-lactam formation. Formation of the 4-memberedThe mechanism and the enzyme(s) responsible for
ring likely involves an SNi mechanism in a serine-con-the formation of the monocyclic -lactam ring are still
taining peptide that is distinct from the oxidative for-unresolved in nocardicin A biosynthesis. Enzymes cata-
mation of penicillin and cephalosporin, or the ATP-lyzing the formation of other -lactam structures have
driven -lactam closure in clavam and carbapenembeen found and characterized. Isopenicillin N synthase
biosynthesis. The bioengineering of combinatorial(IPNS) catalyzes -lactam closure in a tripeptide by an
NRPS modules has exciting long-range prospects inoxidative path [62]. -Lactam synthetase (-LS) [63] and
the production of new antibiotics, especially if mod-carbapenam synthetase (CPS) [64], active in the biosyn-
ules with novel activities can be exploited.thesis of clavams and carbapenams/ems, respectively,
require ATP to close a -amino acid precursor. Ring
Experimental Proceduresclosure in nocardicin A is thought to involve a mecha-
nism distinct from either IPNS, or -LS/CPS. Incorpora-
Bacteria and Plasmidstion and stereochemical studies suggest a simple SNi
Wild-type N. uniformis subspecies tsuyamanesis (ATCC 21806) andmechanism, supported by biomimetic model reactions
A. mirum (ATCC 29888) were purchased from the American Type
[15], in which the amide nitrogen of a hypothetical pep- Culture Collection (Manassas, VA). Escherichia coli DH5 was used
tide precursor would displace a presumably activated for routine cloning and plasmid DNA preparation. E. coli BL21 (DE3)
seryl hydroxyl. Ring closure to the -lactam could be expression cells and pET28b vector were purchased from Nova-
gen (Madison, WI). E. coli strain TB1 and pMAL-c2 expression vectorcatalyzed by the NRPS itself, or by a separate set of
were obtained from New England BioLabs (Beverly, MA). Ni2-NTAproteins to activate the serine -hydroxy and cyclize to
resin and the pQE60 vector were obtained from Qiagen (Valencia,the 4-membered ring.
CA). Cosmid libraries were amplified in E. coli XL1-Blue MRF (Stra-
tagene, La Jolla, CA). Cosmid pOJ446 was previously described
Significance [20], and phagemid pBSII SK– (Stratagene), was purchased from
the manufacturer. TOPO-TA cloning vector was obtained from In-
The -lactam antibiotics and -lactamase inhibitors vitrogen (Carlsbad, CA). Nocardicin A was a gift from Fujisawa Phar-
maceuticals Co., Ltd. Osaka, Japan.remain of central importance to the battle against in-
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General Procedures GCGTG–3 and NatRSph, 5–TATAGCATGCTCACCCCTTGCGCA
GCAC–3 in which the underlined bases indicate XbaI and SphIThe QIAprep-Spin plasmid Kit (Qiagen) was used to prepare plasmid
DNA. Restriction and modifying enzymes were purchased from New restriction sites, respectively. The 905 bp amplicon was ligated into
pIJ4070 downstream of the ermE* promoter and the resulting natEngland Biolabs and used according to the manufacturer’s recom-
mendations. Platinum HiFi Taq (Invitrogen) was used for all PCR cassette was excised with BglII and inserted into pULVK2A to pro-
duce pAJL3248, which was transformed into JM110 cells.amplifications. All molecular biology techniques were performed
according to standard methods [65]. Radioactivity was measured
using a Beckman LS 5801 scintillation counter. HPLC analyses were Transformation of N. uniformis by Electroporation
performed on a Perkin-Elmer Series 410 LC Pump equipped with a A 10 ml culture of N. uniformis in Tryptic Soy Broth (TSB) was
Perkin-Elmer 235C diode array detector and an Agilent Technologies incubated overnight at 28C with vigorous shaking. The overnight
series 1100 fitted with a diode array detector. culture (1 mL) was used to inoculate 100 ml of #148G medium
[66] supplemented with 0.85% glycine and 1.5 mg/L isonicotinic
DNA Sequencing and Analysis hydrazide, and grown for 24 hr at 28C. The mycelium was harvested
DNA sequencing was performed at the Biosynthesis & Sequencing by centrifugation (16,000  g, 15 min), washed with 10% sucrose
Facility, Johns Hopkins Medical School, Baltimore, MD. Sequence and 15% glycerol, and finally resuspended in 600 l of 30% PEG,
data were edited, assembled, and analyzed with the Sequencher 10% glycerol solution. The cells were stored in aliquots at –80C
Software (Gene Codes Co., Ann Arbor, MI) and GCG software pack- until use. In each transformation, 2 l of plasmid DNA was added
age (Version 9, Genetics Computer Group, Madison, WI). Start co- to 20 l mycelium. The mixture was transformed by electroporation
dons were assigned by choosing the ATG or GTG furthest upstream on a Gibco BRL Cell-Porator (280V, 4	, fast charge rate), and al-
in the ORFs, in conjunction with a high GC bias in the third position lowed to recover in R2L liquid medium at 28C with shaking (300
of the codons and probable ribosomal binding sites. Database rpm) for 3 hr and plated as described [67].
searches were performed online using BLAST at the National Center
for Biotechnology Information [21]. Disruption Procedure
Antibiotic resistant colonies of N. uniformis were grown in 100 ml
Growth of N. uniformis and Isolation of Genomic DNA of S27M medium for 72 hr. An aliquot (1 mL) of the culture was
Fermentation and DNA isolation were carried out as previously de- used to inoculate fresh S27M medium (100 mL). The procedure was
scribed [18]. repeated three times and 1 ml was plated on S27M plates containing
thiostrepton. Colonies were picked and plated on S27M apramycin
or thiostrepton plates. Colonies exhibiting apras and thior were veri-Preparation of Cosmid Libraries
fied by PCR amplification with primers designed outside the dis-N. uniformis and A. mirum genomic DNA (gDNA) were partially di-
rupted gene of interest. The band, which contained the gene andgested with Sau3AI to give fragments of 30–40 kb in size. These
the thiostrepton resistance cassette, was cloned into pCR4 TOPOfragments were dephosphorylated with shrimp alkaline phospha-
(Invitrogen) vector and sequenced.tase (SAP) and ligated into the HpaI- and BamHI-digested cosmid
vector pOJ446 [20]. The ligation products were packaged with Giga-
pack III Gold Packaging Extract (Stratagene) as described by the HPLC Analysis of Disruption Mutants
manufacturer, and the resulting phage was used to infect E. coli Starter cultures (10 mL) of disruption mutants were grown in TSB
XL1-Blue MRF cells. The N. uniformis library, consisting of 2500 medium with antibiotic overnight at 28C and 300 rpm, and 1 ml of
apramycin resistant colonies, was screened by hybridization with this preculture was used to inoculate 50 ml of F2 medium [7]. After
the 3-amino-3-carboxytransferase (nat) gene, [18], and later with growing 3–5 days, the culture supernatants were analyzed by HPLC
nocF. Six positive colonies were identified, and the presence of nat using a Phenomenex Luna 5 C18 column (250  4.60 mm; Tor-
in each was confirmed by restriction mapping, sequencing, and rance, CA) under isocratic conditions (10% acetonitrile/90% water
hybridization. Screening with the nocF primer resulted in identifica- /0.01% TFA, 1 mL/min).
tion of 10 additional cosmid clones.
Purification of NocB and 150 kDa Protein
nat Disruption Construct N. uniformis cells (60 g) were suspended in lysis buffer (150 mM
nat was PCR amplified from plasmid pSDB05-152 [18] using the Tris [pH 7.5], 150 mM KCl, 10 mM DTT, 10 mM MgCl2,1 mM EDTA,
primers NatF–5 GGAATTCCATATGACCGCGCTGTCACGCGTG–3 1 mM benzamidine, 1 M leupeptin, 0.1 M pepstatin A, 5 mg/L
and NatR–5 AACAACGCTCTTCCGCACCCCTTGCGCAGCACGA soybean trypsin inhibitor, and 45% glycerol). Cells were ruptured
TGC–3 where underlined bases represent NdeI or SapI restriction at 4C by sonication (Bransonic, model W-225R) at 50% duty, power
sites. A thiostrepton resistance cassette was inserted into the level 7, for 5 min and centrifuged (14,600  g, 20 min, 4C). Nucleic
cloned nat using a unique NcoI site. The resulting plasmid, pJRI- acids were precipitated with streptomycin sulfate and the protein
44, was digested with BamHI and HindIII and ligated into the corre- pellet obtained between 20% and 60% saturation with (NH4)2SO4
sponding sites of pULVK2A to create pAJL3118. Disruption con- was dissolved in the minimum amount of buffer A (100 mM Tris [pH
structs were confirmed by restriction digests and sequencing, and 7.5], 5 mM DTT, 2 mM MgCl2, 0.1 mM EDTA, and 15% glycerol) and
transformed into JM110. dialyzed overnight against 2 liters of the same. The dialyzed extract
was diluted with buffer A and applied to a Q-Sepharose column,
which was then washed with buffer A and subjected to a linearA4 Disruption Construct
gradient of 0–500 mM KCl. The fractions containing NocB (as deter-The A4 adenylation domain was PCR amplified from N. uniformis
mined by ATP/PPi exchange activity for L-pHPG) were pooled andgDNA using the primers BA4F, 5–GAAGAACCATGGCCTTTGCAGT
concentrated in an Amicom ultrafiltration cell equipped with a PM30GCGCGACCTG–3 and BA4R 5–GAAGAACTCGAGGGTCTCGGGC
membrane. The concentrated Q-Sepharose pool was applied to aGCGGCGG–3, in which the underlined bases indicate NcoI and
Sephacryl S300-HR column and eluted with buffer A. Again, theXhoI restriction sites, respectively, and the bolded base indicates
fractions catalyzing ATP/PPi exchange in the presence of L-pHPGa G to A substitution for cloning purposes. The purified amplicon
were pooled and applied to a Pharmacia MONO Q HR 5/5 FPLCwas ligated into corresponding sites in pBSKII–. The thiostrepton
column as a final purification step to separate NocB and the 150resistance cassette was inserted at the unique BclI site of the cloned
kDa enzyme. The mobile phase consisted of 30 mM Tris (pH 7.4),fragment. The disruption construct was then digested with ApaI and
1 mM DTT, and 10% glycerol. Elution occurred under a shallowligated into the pULVK2A vector to produce pAJL3126. Disruption
gradient of 300 mM to 475 mM KCl at 0.5 mL/min.constructs were confirmed by restriction digests and sequencing,
and transformed into JM110 cells.
ATP/PPi Exchange Assay
The reaction mixture (100 L) consisted of 72.5 mM HEPES (pHnat Complementation Construct
The following primers were used to PCR amplify nat from N. uni- 7.5), 7.3% glycerol, 14.5 mM MgCl2, 7.3 mM ATP, 2.9 mM DTT, 0.29
mM EDTA, 1.5 mM substrate, and 20 Ci [32P]-PPi. The assay wasformis gDNA, NatFXba, 5–TATATCTAGAGTGACCGCGCTGTCAC
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initiated with 25 l enzyme sample and incubated 30 min at 37C. 5 min 100% A/0% B, 20 min linear gradient from 100% A/0% B to
80% A/20% B, 5 min 80% A/20% B, 10 min 100% A/0% B. TheThe reaction was quenched by the addition of 400 l 0.5 M HClO4
and 400l 100 mM unlabeled PPi. A 4% w/v suspension of activated elution of components was monitored at 270 nm.
charcoal in dH2O was added to the sample followed by vortexing
and centrifugation. The supernatant was removed and the charcoal Assay of nocF Product Stereochemistry
pellet washed three times with dH2O, and transferred to a scintilla- A 10-times scale NocF activity assay was performed and the compo-
tion vial for analysis. Later analyses of the expressed A-domains nents were separated by HPLC using a Phenomenex Luna C18 (5)
used a simplified procedure [68, 69]. semipreparative column (250 10 mm) using the gradient described
above. The peak corresponding to pHMA was collected for each
injection, lyophilized, and resuspended in 200 l ddH2O. The com-N-Terminal Sequence Determination of NocB
and 150 kDa Protein pound was analyzed on an Astec Chirobiotic T (250 4.6 mm) chiral
column (Whippany, NJ) using an isocratic gradient of 20% methanol,Purified NocB and 150 kDa protein were analyzed on a 6.5% SDS-
PAGE gel, transblotted onto a polyvinylidene fluoride membrane 1% triethylammonium acetate (pH 4.5).
according to a standard protocol [65]. The bands corresponding to
NocB and the 150 kDa protein were excised for N-terminal se- Assay of NocN Activity
quencing. The assay mixture (500 L) contained 50 mM Tris buffer (pH 8) and
2 mM (R,S) p-hydroxymandelic acid, or S-pHMA alone. The reaction
was initiated with the addition of partially purified NocN at a finalCloning L-pHPG Biosynthetic Genes
The coding regions for NocF, NocN, and NocG were PCR amplified concentration of 0.1 mg/mL (50 L). Formation of p-hydroxybenzyl-
formate (pHBF) was monitored spectrophotometrically at 332 nm.from N. uniformis gDNA with primers nocF-NcoI (5-TATACCA
TGGCGGCACAGGCAGGC–3) and nocF-Hind (5-TTATAAGCTT Alternately, the production of pHBF was monitored by HPLC under
the conditions used above for NocF activity.GCGCTCGGTCCGGTGGC-3) for NocF, nocN-EcoRI (5-AGAATTC
GGCGTCCGCAACTCCGCAG-3) and nocN-CtermHind (5-AAT
AAGCTTTCAGGGCGCACCTCGCC-3) for NocN, nocG-EcoRI (5- Acknowledgments
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